The Discounted Cash Flow (DCF) valuation of Collegium Pharmaceutical Inc (COLL) is 16.70 USD. With the latest stock price at 30.09 USD, the upside of Collegium Pharmaceutical Inc based on DCF is -44.5%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 21.3% | 13.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (3.03) - 426.54 | 16.70 |
| Upside | -110.1% - 1317.5% | -44.5% |